Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

被引：13
作者：
Hasan, S. [1 ,2 ,3 ]
Cassinat, B. [4 ]
Droin, N. [1 ,2 ,3 ]
Le Couedic, J. P. [1 ,2 ,3 ]
Favale, F. [1 ,2 ,3 ]
Monte-Mor, B. [1 ,2 ,3 ]
Lacout, C. [1 ,2 ,3 ]
Fontenay, M. [5 ]
Dosquet, C. [4 ]
Chomienne, C. [4 ,6 ]
Solary, E. [1 ,2 ,3 ]
Villeval, J. L. [1 ,2 ,3 ]
Casadevall, N. [1 ,7 ]
Kiladjian, J. J. [8 ]
Vainchenker, W. [1 ,2 ,3 ]
Plo, I. [1 ,2 ,3 ]
机构：
[1] INSERM, UMR 1009, Lab Excellence GR Ex, Villejuif, France
[2] Univ Paris 11, Inst Gustave Roussy, UMR 1009, Villejuif, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Hop St Louis, AP HP, Serv Biol Cellulaire, Paris, France
[5] Hop Cochin, AP HP, Serv Hematol Biol, F-75674 Paris, France
[6] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France
[7] Hop St Antoine, AP HP, Hematol Lab, F-75571 Paris, France
[8] Hop St Louis, AP HP, Ctr Invest Clin, Paris, France
来源：
LEUKEMIA | 2014年 / 28卷 / 02期
关键词：
TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; HEMATOPOIETIC STEM; MUTATION; DISORDERS; JAK2V617F; CELLS;
D O I：
10.1038/leu.2013.303
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：460 / 463
页数：5
相关论文
共 50 条
  • [21] Clonal analysis of erythroid progenitors suggests that pegylated interferon α-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells
    Kiladjian, J-J
    Masse, A.
    Cassinat, B.
    Mokrani, H.
    Teyssandier, I.
    le Couedic, J-P
    Cambier, N.
    Almire, C.
    Pronier, E.
    Casadevall, N.
    Vainchenker, W.
    Chomienne, C.
    Delhommeau, F.
    LEUKEMIA, 2010, 24 (08) : 1519 - 1523
  • [22] JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients
    Wang, Hui
    Sun, Guixiang
    Zhang, Peijin
    Zhang, Jing
    Gui, Er
    Zu, Maoheng
    Jia, Enzhi
    Xu, Hao
    Xu, Lichun
    Zhang, Jinpeng
    Lu, Zhaojun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 208 - 214
  • [23] Clonal analyses reveal associations of JAK2V617F homozygosity with hematologic features, age and gender in polycythemia vera and essential thrombocythemia
    Godfrey, Anna L.
    Chen, Edwin
    Pagano, Francesca
    Silber, Yvonne
    Campbell, Peter J.
    Green, Anthony R.
    HAEMATOLOGICA, 2013, 98 (05) : 718 - 721
  • [24] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Mayumi Tanaka
    Toshiaki Yujiri
    Shunsuke Ito
    Naoko Okayama
    Toru Takahashi
    Kenji Shinohara
    Yoichi Azuno
    Ryouhei Nawata
    Yuji Hinoda
    Yukio Tanizawa
    International Journal of Hematology, 2013, 97 : 409 - 413
  • [25] The survivin/XIAP suppressant YM155 impairs clonal growth and induces apoptosis in JAK2V617F cells
    Carlos, Jorge Antonio Elias Godoy
    Lima, Keli
    Rego, Eduardo Magalha
    Costa-Lotufo, Leticia Veras
    Machado-Neto, Joao Agostinho
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S217 - S227
  • [26] The Combination of JAK2V617F Allele Burden and WT1 Expression can Be Helpful in Distinguishing the Subtype of MPN Patients
    Wu, Sanyun
    Luo, Ping
    Rouzi, Tuerxunayi
    Yu, Yalan
    Xiong, Bei
    Wang, Yingying
    Zuo, Xuelan
    CANCER CONTROL, 2023, 30
  • [27] The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms
    Trifa, Adrian P.
    Cucuianu, Andrei
    Petrov, Ljubomir
    Urian, Laura
    Militaru, Mariela S.
    Dima, Delia
    Pop, Ioan V.
    Popp, Radu A.
    ANNALS OF HEMATOLOGY, 2010, 89 (10) : 979 - 983
  • [28] The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis
    Qin, Youwen
    Wang, Xiaorui
    Zhao, Chuxian
    Wang, Chun
    Yang, Yining
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (02) : 170 - 180
  • [29] JAK2 haplotype 46/1 and JAK2 V617F allele burden in MPN: New evidence against the "hypermutability" hypothesis?
    Stolyar, M. A.
    Klimova, O. A.
    Gorbenko, A. S.
    Brenner, E. V.
    Titov, S. E.
    Ivanov, M. K.
    Olkhovskiy, I. A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : E8 - E10
  • [30] Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia
    Richsten, Anne
    Palmqvist, Lars
    Johansson, Peter
    Andreasson, Bjoern
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (08): : 1260 - 1261
12345